Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-03-24 | Dr. Horning was the Chief Medical Officer and Global Head of Product Development of Roche, Inc., until her retirement in 2019. During her 10-year career at Roche and Genentech, she helped bring 15 new medicines to patients in disease areas including cancer, multiple sclerosis, influenza and blindness. Prior to her career at Roche, Dr. Horning spent 25 years as a practicing oncologist, investigator and tenured professor at Stanford University School of Medicine, where she remains a professor of medicine emerita. |
| 2021-03-30 | Dr. Horning was the Chief Medical Officer and Global Head of Product Development of Roche, Inc.... Medical professional with experience treating patients as a practicing oncologist. |
| 2022-03-24 | Dr. Horning was the Chief Medical Officer and Global Head of Product Development of Roche, Inc... Medical professional with experience treating patients as a practicing oncologist. |
| 2023-03-23 | Dr. Horning was the Chief Medical Officer and Global Head of Product Development of Roche, Inc... She helped bring 15 new medicines to patients... She was a practicing oncologist and professor of medicine emerita. |
| 2024-03-28 | Dr. Horning joined our Board in January 2020. Dr. Horning was the Chief Medical Officer and Global Head of Product Development of Roche, Inc., until her retirement in 2019. During her 10-year career at Roche and Genentech, she helped bring 15 new medicines to patients in disease areas including cancer, multiple sclerosis, influenza and blindness. Prior to her career at Roche, Dr. Horning spent 25 years as a practicing oncologist, investigator and tenured professor at Stanford University School of Medicine, where she remains a professor of medicine emerita. From 2005 to 2006, she served as President of the American Society of Clinical Oncology. Dr. Horning was recognized as the 2020 Healthcare Businesswomen’s Association Woman of the Year. She was also selected as the 2017 recipient of the Duane Roth Memorial Award, an honor dedicated to leaders in healthcare, whose work has overcome numerous scientific obstacles to create new paradigms in research and treatment. Dr. Horning previously served on the board of directors of Foundation Medicine, Inc. from 2015 to 2018 and EQRx, Inc. from 2021 to 2023. She currently serves on the board of directors of Moderna, Inc., Olema Pharmaceuticals, Inc. and Revolution Medicines, Inc. |
| 2025-03-27 | Dr. Horning was the Chief Medical Officer and Global Head of Product Development of Roche, Inc., and a practicing oncologist. She has leadership experience in drug development in multiple therapeutic areas. |
Data sourced from SEC filings. Last updated: 2025-08-30